Last reviewed · How we verify

NCT06163196: acupressure

The Effect of Acupressure on Pain in Children With Thalassemia

Completed NA Last updated 8 December 2023
What this trial tests

NA trial testing acupressure in Pain in 39 participants. Completed in 4 June 2022.

Timeline
4 June 2022
Primary endpoint
4 June 2022
4 June 2022

Quick facts

Lead sponsorMersin University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposesupportive care
Enrollment39
Start date4 June 2022
Primary completion4 June 2022
Estimated completion4 June 2022
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Mersin University

Who can join

Adults 6 to 18, any sex, with Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This randomized controlled trial evaluates the effect of acupressure on reducing the pain of blood collection in children with Thalassemia. The hypothesis of this study is that acupressure application reduces acute pain.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of acupressure

Trials testing the same drug.

Other recruiting trials for Pain

Currently open trials in the same condition.

Other Mersin University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06163196.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing